82.76 USD
-0.2 (-0.24%)
LMAT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. LMAT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LMAT is not valued too expensively and it also shows a decent growth rate. With these ratings, LMAT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
In the past year LMAT had a positive cash flow from operations.
In the past 5 years LMAT has always been profitable.
Each year in the past 5 years LMAT had a positive operating cash flow.
1.2 Ratios
The Return On Assets of LMAT (8.92%) is better than 91.40% of its industry peers.
LMAT's Return On Equity of 14.08% is amongst the best of the industry. LMAT outperforms 90.32% of its industry peers.
LMAT's Return On Invested Capital of 8.43% is amongst the best of the industry. LMAT outperforms 87.10% of its industry peers.
LMAT had an Average Return On Invested Capital over the past 3 years of 8.26%. This is in line with the industry average of 8.84%.
The last Return On Invested Capital (8.43%) for LMAT is above the 3 year average (8.26%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROIC | 8.43% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
With an excellent Profit Margin value of 22.14%, LMAT belongs to the best of the industry, outperforming 94.09% of the companies in the same industry.
In the last couple of years the Profit Margin of LMAT has grown nicely.
Looking at the Operating Margin, with a value of 25.71%, LMAT belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
LMAT's Operating Margin has improved in the last couple of years.
LMAT has a Gross Margin of 70.97%. This is in the better half of the industry: LMAT outperforms 79.03% of its industry peers.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LMAT is destroying value.
LMAT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, LMAT has more shares outstanding
Compared to 1 year ago, LMAT has a worse debt to assets ratio.
2.2 Solvency
LMAT has an Altman-Z score of 7.14. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.14, LMAT belongs to the top of the industry, outperforming 86.02% of the companies in the same industry.
LMAT has a debt to FCF ratio of 2.54. This is a good value and a sign of high solvency as LMAT would need 2.54 years to pay back of all of its debts.
LMAT's Debt to FCF ratio of 2.54 is amongst the best of the industry. LMAT outperforms 84.95% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that LMAT is not too dependend on debt financing.
LMAT has a Debt to Equity ratio (0.44) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Altman-Z | 7.14 |
ROIC/WACC0.98
WACC8.57%
2.3 Liquidity
A Current Ratio of 13.58 indicates that LMAT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 13.58, LMAT belongs to the best of the industry, outperforming 97.85% of the companies in the same industry.
LMAT has a Quick Ratio of 11.45. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 11.45, LMAT belongs to the best of the industry, outperforming 95.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 19.67% over the past year.
The Earnings Per Share has been growing by 17.13% on average over the past years. This is quite good.
LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.07%.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
3.2 Future
Based on estimates for the next years, LMAT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.10% on average per year.
LMAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.65% yearly.
EPS Next Y27.49%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
LMAT is valuated quite expensively with a Price/Earnings ratio of 37.79.
Compared to the rest of the industry, the Price/Earnings ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 70.97% of the companies listed in the same industry.
LMAT is valuated rather expensively when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 31.36 indicates a quite expensive valuation of LMAT.
71.51% of the companies in the same industry are more expensive than LMAT, based on the Price/Forward Earnings ratio.
LMAT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.79 | ||
| Fwd PE | 31.36 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 77.96% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LMAT is valued cheaply inside the industry as 80.11% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.35 | ||
| EV/EBITDA | 19.25 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of LMAT may justify a higher PE ratio.
LMAT's earnings are expected to grow with 14.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)2.21
EPS Next 2Y16.63%
EPS Next 3Y14.06%
5. Dividend
5.1 Amount
LMAT has a yearly dividend return of 0.95%, which is pretty low.
Compared to an average industry Dividend Yield of 0.20, LMAT pays a better dividend. On top of this LMAT pays more dividend than 91.94% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.95% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
32.20% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.2%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
NASDAQ:LMAT (12/30/2025, 11:45:34 AM)
82.76
-0.2 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.15%
Inst Owner Change-3.91%
Ins Owners7.89%
Ins Owner Change-4.67%
Market Cap1.88B
Revenue(TTM)240.87M
Net Income(TTM)53.34M
Analysts78.82
Price Target105.74 (27.77%)
Short Float %5.41%
Short Ratio6.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.95% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP32.2%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.59%
Min EPS beat(2)3.81%
Max EPS beat(2)7.38%
EPS beat(4)2
Avg EPS beat(4)0.79%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.68%
EPS beat(12)9
Avg EPS beat(12)4.66%
EPS beat(16)9
Avg EPS beat(16)-0.71%
Revenue beat(2)1
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.64%
PT rev (3m)-1.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.07%
EPS NY rev (1m)6.3%
EPS NY rev (3m)6.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.16%
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-0.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.79 | ||
| Fwd PE | 31.36 | ||
| P/S | 7.8 | ||
| P/FCF | 28.35 | ||
| P/OCF | 25.63 | ||
| P/B | 4.96 | ||
| P/tB | 6.68 | ||
| EV/EBITDA | 19.25 |
EPS(TTM)2.19
EY2.65%
EPS(NY)2.64
Fwd EY3.19%
FCF(TTM)2.92
FCFY3.53%
OCF(TTM)3.23
OCFY3.9%
SpS10.62
BVpS16.7
TBVpS12.4
PEG (NY)1.37
PEG (5Y)2.21
Graham Number28.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROCE | 10.97% | ||
| ROIC | 8.43% | ||
| ROICexc | 21.47% | ||
| ROICexgc | 38.36% | ||
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% | ||
| FCFM | 27.5% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 68.51% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.46% | ||
| Profit Quality | 124.17% | ||
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 | ||
| Altman-Z | 7.14 |
F-Score5
WACC8.57%
ROIC/WACC0.98
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
EPS Next Y27.49%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
EBIT growth 1Y24.85%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year45.26%
EBIT Next 3Y22.27%
EBIT Next 5YN/A
FCF growth 1Y189.96%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y143.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
Can you provide the valuation status for LEMAITRE VASCULAR INC?
ChartMill assigns a valuation rating of 5 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 37.79 and the Price/Book (PB) ratio is 4.96.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 27.49% in the next year.